St. Jude Medical (STJ) Announces First Implant of Portico Transcatheter Heart Valve  
6/7/2011 9:49:12 AM

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first human implant of its Porticoâ„¢ transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.